Anatomic and functional outcome of triamcinolone-assisted 23-gauge vitrectomy in vitreomacular traction syndrome


Toklu Y., Demirel S., Sarac O., Cakmak H. B. , ÇAĞIL N.

Seminars in Ophthalmology, vol.27, no.3-4, pp.73-77, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 3-4
  • Publication Date: 2012
  • Doi Number: 10.3109/08820538.2012.680640
  • Title of Journal : Seminars in Ophthalmology
  • Page Numbers: pp.73-77
  • Keywords: 23-gauge vitrectomy, Triamcinolone acetonid, Vitreomacular traction, TRANSCONJUNCTIVAL SUTURELESS VITRECTOMY, PARS-PLANA VITRECTOMY, VISUAL OUTCOMES, 20-GAUGE VITRECTOMY, RETINAL-DETACHMENT, MACULAR HOLE, SURGERY, ACETONIDE

Abstract

Purpose: To evaluate the outcomes of patients with vitreomacular traction syndrome (VMT) treated with triamcinolone acetonid (TA) assisted 23-gauge (23-G) transconjunctival sutureless vitrectomy. Methods: Restrospective, case series. The medical charts of 13 eyes of 13 consecutive patients with VMT who underwent 23-gauge transconjunctival pars plana vitrectomy were reviewed. All patients had at least six-month follow-up. The main outcome parameters were changes in best corrected visual acuity (BCVA) and central macular thickness (CMT) between the baseline and postoperative follow- up examinations performed at the first, third, and sixth months after the surgery. Results: The mean follow-up period was 7 (range 615) months. The mean preoperative BCVA was 1.3±0.4 (logmar). The final BCVA was 0.5±0.3 (logmar) (p = 0.001). The mean CMT was 429±85 m at baseline, which was significantly reduced to 255±47 m at the final follow-up visit (p = 0.001). The mean CMT reduction was 174±101 (range: 32348) m. No postoperative complications were seen such as endophthalmitis, retinal detachment, hypotony, or glaucoma. Conclusion: Triamcinolone assisted 23-G transconjunctival sutureless vitrectomy is an effective and safe surgical technique in the management of VMT syndrome. Further studies with large case series are needed. © 2012 Informa Healthcare USA, Inc.